DURECT Corporation (NASDAQ:DRRX) headquartered in Cupertino, will host a conference call for the investment community to discuss the 2Q20 earnings result on 3rd August 2020 at 4:30 PM Eastern Time.
Those interested in listening to the conference call live via the Internet can visit www.durect.com
Earnings Expectation
DURECT Corporation is set to announce second quarter earning results on Monday 3rd August 2020, after market close.
Analysts surveyed by Thomson Reuters are predicting, DRRX to report 2Q20 revenue of $ 11.48 million. For the full year, analysts anticipate top line of $ 24.05 million, while looking forward to loss of $ 0.14 per share bottom line.
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for experimental research in mice, rats, and other laboratory animals; and a range of biodegradable polymers for pharmaceutical and medical device clients for use as raw materials in their products under the LACTEL brand. Its product pipeline consists of multiple investigational drug candidates in development, such as DUR-928, an endogenous, orally bioavailable small molecule that is in Phase I and II development stage to play a regulatory role in lipid homeostasis, inflammation, and cell survival.
